The introduction of nicotinamide like a nicotine replacement in e-cigarette and smokeless items represents a major regulatory problem with the FDA. Nicotinamide does not have nicotinic receptor agonist exercise and is understood to work as a sedative at higher dosages6. The promises produced by Nicotine River, ECBlend, and other vendors that their